• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS ELEMENT PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS ELEMENT PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 9386
Device Problem Obstruction of Flow (2423)
Patient Problem Reocclusion (1985)
Event Date 04/22/2019
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.
 
Event Description
Evolve china clinical study- it was reported that in-stent restenosis occurred.In (b)(6) 2014, the patient presented with unstable angina as well as other objective evidence of ischemia and was referred for cardiac catheterization.Subsequently, the index procedure was performed.The target lesion #1 was located in the mid left anterior descending artery with 80% stenosis and was 15mm long with a reference vessel diameter of 3.5mm.The lesion was treated with pre-dilatation and placement of a 3.5mmx 20mm study stent, resulting in 0% stenosis.Two days post procedure, the patient was discharged on acetylsalicylic acid and clopidogrel.In (b)(6) 2019, the patient was noted with an in-stent restenosis and was hospitalized on the same day.The patient underwent percutaneous coronary intervention and blood transfusion was also carried out to treat the event.The event was considered to be recovered/resolved the same day.
 
Event Description
Evolve china clinical study.It was reported that in-stent restenosis occurred.In (b)(6) 2014, the patient presented with unstable angina as well as other objective evidence of ischemia and was referred for cardiac catheterization.Subsequently, the index procedure was performed.The target lesion #1 was located in the mid left anterior descending artery with 80% stenosis and was 15mm long with a reference vessel diameter of 3.5mm.The lesion was treated with pre-dilatation and placement of a 3.5mmx 20mm study stent, resulting in 0% stenosis.Two days post procedure, the patient was discharged on acetylsalicylic acid and clopidogrel.In (b)(6) 2019, the patient was noted with an in-stent restenosis and was hospitalized on the same day.The patient underwent percutaneous coronary intervention and blood transfusion was also carried out to treat the event.The event was considered to be recovered/resolved the same day.It was further reported in (b)(6) 2019, coronary angiography revealed the in-stent restenosis was located in the proximal part of lad with 80% stenosis.Post intervention, the residual stenosis was 0%.At the time of reporting the patient was still hospitalized.
 
Manufacturer Narrative
Device is a combination product.
 
Event Description
Evolve china clinical study.It was reported that in-stent restenosis occurred.In (b)(6) 2014, the patient presented with unstable angina as well as other objective evidence of ischemia and was referred for cardiac catheterization.Subsequently, the index procedure was performed.The target lesion #1 was located in the mid left anterior descending artery with 80% stenosis and was 15mm long with a reference vessel diameter of 3.5mm.The lesion was treated with pre-dilatation and placement of a 3.5mmx 20mm study stent, resulting in 0% stenosis.Two days post procedure, the patient was discharged on acetylsalicylic acid and clopidogrel.In (b)(6) 2019, the patient was noted with an in-stent restenosis and was hospitalized on the same day.The patient underwent percutaneous coronary intervention and blood transfusion was also carried out to treat the event.The event was considered to be recovered/resolved the same day.It was further reported in (b)(6) 2019, coronary angiography revealed the in-stent restenosis was located in the proximal part of lad with 80% stenosis.Post intervention, the residual stenosis was 0%.At the time of reporting the patient was still hospitalized.It was further reported in (b)(6) 2019, two days after intervention was completed, the event was considered recovered/resolved and the patient was discharged the same day.
 
Manufacturer Narrative
Device is a combination product.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key8575477
MDR Text Key143889326
Report Number2134265-2019-04788
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 01/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/02/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/11/2014
Device Model Number9386
Device Catalogue Number9386
Device Lot Number0016108453
Was Device Available for Evaluation? No
Date Manufacturer Received12/29/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age57 YR
-
-